FORMULATION

This invention relates to pharmaceutical compositions comprising a compound comprising a TLR2 agonist moiety conjugated with a solubilising moiety and an excipient that stabilises the compound under accelerated aging conditions. Also disclosed is the preparation of powdered forms of the compositions...

Full description

Saved in:
Bibliographic Details
Main Author MCLACHLAN, Grant
Format Patent
LanguageEnglish
Published 29.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to pharmaceutical compositions comprising a compound comprising a TLR2 agonist moiety conjugated with a solubilising moiety and an excipient that stabilises the compound under accelerated aging conditions. Also disclosed is the preparation of powdered forms of the compositions and methods for their use.
Bibliography:Application Number: AU20220338350